(Q34312653)

1 August 2017

1 reference

title

Proof of principle trials: exploratory open studies (English)

1 reference

1 August 2017

Schmidt D

1

1 reference

1 August 2017

publication date

1 May 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

45

1 reference

1 August 2017

issue

1-3

1 reference

1 August 2017

page(s)

15-8; discussion 19-21

1 reference

Randomised, placebo-controlled study of vigabatrin as first-line treatment of infantile spasms

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900206-6

7 January 2021

Acute effects of lamotrigine (BW430C) in persons with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900206-6

7 January 2021

Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900206-6

7 January 2021

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900206-6

7 January 2021

Lamotrigine: single-dose pharmacokinetics and initial 1 week experience in refractory epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900206-6

7 January 2021

Photosensitive epilepsy: a model to study the effects of antiepileptic drugs. Evaluation of the piracetam analogue, levetiracetam

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900206-6

7 January 2021

Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900206-6

7 January 2021

Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900206-6

7 January 2021

Oxcarbazepine: Double-blind, randomized, placebo-control, monotherapy trial for partial seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900206-6

7 January 2021

Oxcarbazepine for Treatment of Partial Epilepsy: A Review and Recommendations for Clinical Use

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900206-6

7 January 2021

Progabide for refractory partial epilepsy: a controlled add-on trial

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900206-6

7 January 2021

Double-blind, placebo-controlled evaluation of cinromide in patients with the Lennox-Gastaut Syndrome. The Group for the Evaluation of Cinromide in the Lennox-Gastaut Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900206-6

7 January 2021

Pharmacokinetics of W-554 (ADD 03055) in epileptic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2801%2900206-6

7 January 2021

10.1016/S0920-1211(01)00206-6

Identifiers

DOI

1 reference

1 August 2017

1 reference